Immune-mediated necrotizing myopathy (IMNM) is a group of inflammatory myopathies that
was distinguished from polymyositis in 2004. Most IMNMs are associated with anti-signal …

Introduction: Musculoskeletal manifestations are well-recognized side effects of treatment
with statins. New advances in this field have appeared in recent years. This review focuses …

Where are we moving in the classification of idiopathic infl... : Current Opinion in Neurology
Where are we moving in the classification of idiopathic inflammatory myopathies? : Current …

Anti-HMGCR myopathy was first recognized and characterized in patients with a history of
statin exposure and immune-mediated necrotizing myopathy. After the discovery of anti …

Objective: To evaluate the diagnostic value of myxovirus resistance A (MxA) expression in
the cytoplasm of myofibers in the diagnosis of dermatomyositis (DM). Methods: We assessed …

Classification of idiopathic inflammatory myopathies: pathol... : Current Opinion in
Neurology Classification of idiopathic inflammatory myopathies: pathology perspectives …

The major forms of autoimmune myopathies include dermatomyositis (DM), polymyositis
(PM), myositis associated with antisynthetase syndrome (ASS), immune-mediated …

Autoimmune myopathies (myositides) are strongly associated with malignancy. The link
between myositis and cancer, originally noticed by Bohan and Peter in their classification in …

Objective To determine the prevalence and clinical features of anti-HMGCR myopathy
among patients with presumed limb-girdle muscular dystrophy (LGMD) in whom genetic …

Diffuse myofiber necrosis in the context of inflammatory myopathy is the hallmark of immune‐
mediated necrotizing myopathy (IMNM). We have previously shown that skeletal muscle …